{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:08:03Z","timestamp":1793156883430,"version":"4.5.0"},"reference-count":72,"publisher":"Informa UK Limited","issue":"1-2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1080\/13543784.2025.2463092","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T09:28:16Z","timestamp":1739179696000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["CD38 monoclonal antibody felzartamab for late antibody-mediated rejection: a phase II drug evaluation"],"prefix":"10.1080","volume":"34","author":[{"given":"Katharina A.","family":"Mayer","sequence":"first","affiliation":[{"name":"Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemens","family":"Budde","sequence":"additional","affiliation":[{"name":"Charit\u00e9-Universit\u00e4tsmedizin Berlin","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Schatzl","sequence":"additional","affiliation":[{"name":"Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Schrezenmeier","sequence":"additional","affiliation":[{"name":"Charit\u00e9-Universit\u00e4tsmedizin Berlin","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Diebold","sequence":"additional","affiliation":[{"name":"Medical University of Vienna","place":["Vienna, Austria"]},{"name":"University Hospital Basel","place":["Basel, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Jilma","sequence":"additional","affiliation":[{"name":"Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg A.","family":"B\u00f6hmig","sequence":"additional","affiliation":[{"name":"Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003274"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03840.x"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003192"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020081215"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003095"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.11.029"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000005187"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2023.10.016"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/iji.12532"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2024.13318"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-740944"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01187"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00451.2021"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-12-687749"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1605684"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003604"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2023325"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002742"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2024.06.018"},{"key":"e_1_3_3_22_1","unstructured":"Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy (IGNAZ). NCT05065970. Bethesda (MD): US National Library of Medicine; 2021 Available from: https:\/\/clinicaltrials.gov\/study\/NCT06285201?cond=NCT05065970"},{"key":"e_1_3_3_23_1","unstructured":"Efficacy Safety and PK\/PD of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) (NewPLACE) (NewPLACE). NCT04733040. Bethesda (MD): US National Library of Medicine; 2021 Available from: https:\/\/clinicaltrials.gov\/study\/NCT06285201?cond=NCT04733040"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2400763"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018121254"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1159\/000503951"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003247"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1087597"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X231211050"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/tan.15458"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001685"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2024.13213"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000004550"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2003.00072.x"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1802677"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002049"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2023.11381"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.15383"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14520"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00079"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017070818"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e318190af83"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181a4b91b"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020071106"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-022-06897-3"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00791-0"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14228"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002895"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-024-08020-0"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2012.212"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12706"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14001"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14528"},{"key":"e_1_3_3_54_1","unstructured":"The Safety and Efficacy of CD38 Monoclonal Antibody Monotherapy for CaAMR in Renal Transplantation. NCT05913596. Bethesda (MD): US National Library of Medicine; 2023 [updated 2023 Sep 14; cited 2024 Nov 14] Available from: https:\/\/clinicaltrials.gov\/study\/NCT06285201?cond=NCT05913596"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V120.21.4018.4018"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.3015.3015"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017006866"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1597"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI179561"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2022.11.010"},{"key":"e_1_3_3_61_1","unstructured":"Felzartamab in Late Antibody-Mediated Rejection. NCT05021484. Bethesda (MD): US National Library of Medicine; 2021 [updated 2024 Apr 17; cited 2024 Nov 14]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06285201?cond=NCT05021484"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2024.08.004"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.0000000000000287"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30249-2"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2024s6p6remb"},{"key":"e_1_3_3_66_1","unstructured":"Barratt J Shah M Kivman L et al. Felzartamab durably reduces disease-relevant biomarkers through targeting of CD38+ Plasma Cells and Plasmablasts the Upstream Drivers of IgAN. ASN Kidney Week. 2024 (Abstract). Available from: https:\/\/www.asn-online.org\/education\/kidneyweek\/2024\/program-abstract.aspx?controlId=4116225"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2024.08.020"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.05.031"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2409970"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12224"},{"key":"e_1_3_3_71_1","unstructured":"Study of Felzartamab in Healthy Adult Subjects. NCT06285201. Bethesda (MD): US National Library of Medicine; 2024 [updated 2024 Sep 20; cited 2024 Nov 14]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06285201?cond=NCT06285201"},{"key":"e_1_3_3_72_1","unstructured":"A study of felzartamab in participants with lupus Nephritis. NCT06064929. Bethesda (MD): US National Library of Medicine; 2023 [updated 2024 Sep 25; cited 2024 Nov 14].Available from: https:\/\/clinicaltrials.gov\/study\/NCT06285201?cond=NCT06064929"},{"key":"e_1_3_3_73_1","unstructured":"MOR202 for Refractory MN (MONET). NCT04893096. Bethesda (MD): US National Library of Medicine; 2021 [updated 2024 Sep 29; cited 2024 Nov 14].Available from: https:\/\/clinicaltrials.gov\/study\/NCT06285201?cond=NCT04893096"},{"key":"e_1_3_3_74_1","unstructured":"A Trial of Felzartamab in Kidney Transplant Recipients with Late Antibody-Mediated Rejection (AMR) (TRANSCEND). NCT06685757. Bethesda (MD): US National Library of Medicine; 2024 [updated 2024 Nov 12; cited 2024 Nov 14].Available from: https:\/\/clinicaltrials.gov\/study\/NCT06285201?cond=NCT06685757"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2025.2463092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T07:26:32Z","timestamp":1739863592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2025.2463092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":72,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1080\/13543784.2025.2463092"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2025.2463092","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-12-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}